openPR Logo
Press release

Exanthema Market Research Report by Key Players Analysis 2024

01-02-2018 12:49 PM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Exanthema Market Research Report by Key Players Analysis 2024

Exanthema (exanthem) is rash that affects several areas of the skin. It is generally referred as viral exanthema more common in children. Determining of the exact cause of rashes is difficult as look similar in most of the cases. Hence, other symptoms (such as headache, severe abdominal pain, diarrhea vomiting etc), facilitate the physicians in identifying the type of virus responsible for onset of the disease. This condition is also termed as roseola infantum and is positioned as a sixth rash causing disease in children since, this condition is caused by human herpesvirus 6 (HHV 6). Similar condition is caused by other viruses as well resulting in development of rashes all over the body. These rashes are visible from head to toe and are red and blotchy in appearance. Infants suffering from common viral infections such as cold and sore throat are at the highest risk of acquiring viral exanthems. Several symptoms of exanthem such as severe abdominal pain, stiff neck, diarrhea needs timely treatment. Medication such as acetaminophen (tylenol), penicillin and tetracycline are prescribed for treatment of exanthema. However, certain temporary medications such as NSAIDs can be taken for pains, headache, and others. For instance, Acetaminophen and ibuprofen are prescribed against headaches, fever and body pain. Cool sponge baths are also recommended to reduce the fever to certain extent.

Browse Premium Industry Research Report with Analysis: https://www.transparencymarketresearch.com/exanthema-market.html

Increasing research activities for development of drugs for viral exanthema and increase in incidences of exanthema among the infant are the major driver that drives the growth of exanthema market. In addition, growing awareness of exanthema disease treatment among end user and rising government initiatives for vaccination for infants are anticipated to contribute the growth of the market. However, lack of standard diagnosis procedure for exanthema and lengthy drug development procedure with high cost for research are restraining the growth of the exanthema market.

Request for Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3063

The exanthema market has been segmented by type of disease and by geography. In terms of disease type, the exanthema has been categorized into rubella, roseola, measles, and erythema infectiosum. Geographically, the market is segmented by four major regions namely, Europe, North America, Asia Pacific, Latin America, and Middle East & Africa. North America and European countries represent large market share of the total exanthem market. This is attributed to high awareness levels and favorable government support. Regulatory policies pertaining to drug safety and efficacy play an instrumental role in commercialization and approval of the drugs. Furthermore, strategies such as in licensing and out licensing strategies adopted by the major market players also plays a significant role in drug development process. These market growth can be attributed to the investments done by leading players to develop new products, which will enhance the growth of the exanthema in the developing countries, such as China and India. Latin American countries such as Mexico and Brazil are expected to have considerable potential for driving the market growth due to evolving medical structure, and incidences of exanthema. The major players operating in this market include C.H. Boehringer Sohn AG & Ko. KG, Winston Pharmaceuticals, Inc., GlaxoSmithKline Plc, Johnson & Johnson, and Teva Pharmaceutical Industries Ltd., among other significant players worldwide.

Pre Book this Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=3063<ype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Exanthema Market Research Report by Key Players Analysis 2024 here

News-ID: 881744 • Views: 100

More Releases from Transparency Market Research

Impact of Outbreak of COVID-19 on Medical Education Market : Global Industry Ana …
Transparency Market Research (TMR) has published a new report on the medical education market for the period of 2019–2027. According to the report, the global medical education market was valued at nearly US$ 31 Bn in 2018, and is projected to expand at a CAGR of more than 4% from 2019 to 2027. Rise in the number of medical schools and increase in cost of medical education are the
Healthcare BI Platform Market Companies Analysis, Advancement and Precise Outloo …
In an intensely competitive healthcare business intelligence (BI) platform market, large players are aggressively focused on expanding their geographical outreach, says Transparency Market Research (TMR) in a new market intelligence report. These large players are leveraging the cloud business model to provide healthcare BI solutions that can be accessed irrespective of location. Apart from this, savvy players are entering into partnerships with hospital groups and healthcare bodies to integrate healthcare BI
Substance Abuse Treatment Market News Research Report 2024
A recent report by Transparency Market Research on the substance abuse treatment market in the U.S. states that the competitive landscape is highly fragmented. This is because around 242 companies compete against one another in it. This also makes overall competition stiff. Some of the companies that have beat competition to emerge as leading players in the market are Pfizer Inc., Alkermes Plc, GlaxoSmithKline Plc., and Purdue Pharma LP. Their
Clinical Oncology Next Generation Sequencing Market is Thriving Worldwide By Siz …
Clinical Oncology Next Generation Sequencing: Introduction Next generation sequencing for tumor and germline DNA is required for oncology screening for therapeutic application. Rise in burden of cancer increases the need for early detection of the condition to carry out the generate target therapy. Companies are investing to develop technologically advanced devices/solutions for precision detection. In 2012, Oxford Nanopore had launched the GridION sequencing platform, which can sequence a human genome in 15

All 5 Releases


More Releases for Exanthema

Varicella-Zoster Virus (VZV) Treatment Market - Top Emerging Trends, CAGR, SWOT …
The reports analyses the Global Varicella-Zoster Virus (VZV) Treatment available at InForGrowth.com provides Varicella-Zoster Virus (VZV) Treatment Market Size, Emerging Trends, a profound analysis of CAGR growth rate, its SWOT Analysis, Regulatory Authorities, Expansion Plans, Market Forecast, its Application, Revenue, Industry Chain, Gross Margin, Opportunities, Market Share, Price and more. Varicella-Zoster Virus (VZV) Treatment causes chickenpox and herpes zoster (shingles). Chickenpox follows initial exposure to the virus and is typically a
MoBiTec, Germany, Announces Availability of Human Herpesvirus-6 (HHV-6) Assay Ki …
Human herpesvirus (HHV-) 6 has been associated with various neurological diseases, including encephalitis, meningitis, epilepsy, and multiple sclerosis. MoBiTec partners with VIDIA, Czech Republic, to offer HHV-6 assay kits worldwide. ELISA-VIDITEST and IF-VIDITEST anti-HHV-6 kits are intended for serological diagnosis of diseases associated with HHV–6 infection, such as exanthema subitum, acute respiratory illnesses, diarrhoea with fever and febrile seizures in infants, heterophile antibody-negative infectious mononucleosis in children, also interstitial pneumonia, encephalitis,